Form 4 Tracker
Howard G. Welgus

Director · 9 filings · Latest: Sep 15, 2026

Arcutis Biotherapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARQT
Howard Welgus—Mar 2, 2026
Proposed Sale
$25.6510,000$256.5K—
ARQT
Howard G. WelgusDirectorFeb 2, 2026
Sale
$25.0510,000$250.5K59,744
ARQT
Howard Welgus—Feb 2, 2026
Proposed Sale
$25.0510,000$250.5K—
ARQT
Howard Welgus—Jan 2, 2026
Proposed Sale
$28.9610,000$289.6K—
ARQT
Howard Welgus—Dec 1, 2025
Proposed Sale
$30.2110,000$302.1K—
ARQT
Howard Welgus—Nov 3, 2025
Proposed Sale
$25.2710,000$252.7K—
ARQT
Howard Welgus—Oct 1, 2025
Proposed Sale
$18.9210,000$189.2K—
ARQT
Welgus Howard G.—Sep 2, 2025
Proposed Sale
$15.6110,000$156.1K—
ARQT
Welgus Howard G.—Aug 1, 2025
Proposed Sale
$14.3010,000$143.0K—
ARQT
Welgus Howard G.—Jul 1, 2025
Proposed Sale
$13.849,208$127.4K—
ARQT
Welgus Howard G.—Jun 18, 2025
Proposed Sale
$13.3710,139$135.6K—
ARQT
Welgus Howard G.—May 1, 2025
Proposed Sale
$14.6410,000$146.4K—
ARQT
Welgus Howard G.—Apr 1, 2025
Proposed Sale
$15.1210,000$151.2K—
ARQT
Welgus Howard G.—Mar 3, 2025
Proposed Sale
$13.0010,000$130.0K—
ARQT
Welgus Howard G.—Feb 3, 2025
Proposed Sale
$12.7110,000$127.1K—
ARQT
Welgus Howard G.—Jan 2, 2025
Proposed Sale
$14.6710,000$146.7K—
ARQT
Welgus Howard G.—Dec 2, 2024
Proposed Sale
$12.5110,000$125.1K—
ARQT
Welgus Howard G.—Nov 1, 2024
Proposed Sale
$8.6510,000$86.5K—
ARQT
Welgus Howard G.—Oct 1, 2024
Proposed Sale
$9.2610,000$92.6K—
ARQT
Welgus Howard G.—Sep 3, 2024
Proposed Sale
$10.7710,000$107.7K—

← Previous

Page 2 of 2